|
English
|
正體中文
|
简体中文
|
Items with full text/Total items : 17933/22952 (78%)
Visitors : 7336931
Online Users : 415
|
|
|
Loading...
|
Please use this identifier to cite or link to this item:
https://ir.csmu.edu.tw:8080/ir/handle/310902500/24734
|
Title: | Functional genetic variant of WW domain containing oxidoreductase gene associated with urothelial cell carcinoma clinicopathologic characteristics and long-term survival |
Authors: | Hung, SC;Chou, YE;Li, JR;Chen, CS;Lin, CY;Chang, LW;Chiu, KY;Cheng, CL;Ou, YC;Wang, SS;Yang, SF |
Keywords: | WW domain-containing oxidoreductase gene;Polymorphism;Urothelial cell carcinoma |
Date: | 2020 |
Issue Date: | 2022-08-09T08:07:09Z (UTC)
|
Publisher: | ELSEVIER SCIENCE INC |
ISSN: | 1078-1439 |
Abstract: | Objectives: In Taiwan, urothelial cell carcinoma (UCC) is a common malignancy of urinary tract that is associated with genetic and environmental carcinogens. WW domain-containing oxidoreductase (WWOX) has been identified as a tumor suppressor gene that associated with several cancers development and progression. The study aimed to explore the impact of WWOX gene polymorphisms on the clinicopathological status and prognosis of patients with UCC. Materials and methods: A total of 1,293 participants, including 431 patients with UCC and 862 healthy controls, were recruited for this study. Five polymorphisms of the WWOX gene were examined by a real-time PCR assay. Results: We found that individuals carrying TT polymorphism at rs11545028 and at least 1 G allele at rs3764340 associated with more susceptible to UCC. At least 1 A allele at rs12918952 associated with more advance disease and high grade tumor. Patients with T allele at rs11545028 associated with worse relapse free survival in all patients and worse disease specific survival (DSS) in male. Patients with A allele at rs12918952 associated with worse DSS in all patients and worse relapse free survival, DSS and overall survival in male. Conclusions: This is the first reported correlation between WWOX polymorphisms and UCC risk and clinicopathologic feature. Genetic variants of WWOX contribute to the pathologic staging, grading, and prognosis. The findings regarding these biomarkers provided a potential prediction of UCC progression. (C) 2019 Elsevier Inc. All rights reserved. |
URI: | http://dx.doi.org/10.1016/j.urolonc.2019.07.016 https://www.webofscience.com/wos/woscc/full-record/WOS:000506208200014 https://ir.csmu.edu.tw:8080/handle/310902500/24734 |
Relation: | UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS ,2020 ,v38 ,issue 2 |
Appears in Collections: | [中山醫學大學研究成果] 期刊論文
|
Files in This Item:
File |
Description |
Size | Format | |
index.html | | 0Kb | HTML | 210 | View/Open |
|
All items in CSMUIR are protected by copyright, with all rights reserved.
|